GALMED PHARMACEUTICALS LTD. Financing Cash Flow
GALMED PHARMACEUTICALS LTD. (GLMD) reported Financing Cash Flow of $1.20 million for the 6-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $1.19M, a 165.18% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $289.00K.
- GALMED PHARMACEUTICALS LTD. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $448.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.20M 6-K · filed 2026-09-02 | |||
| 2025-12-31 | $1.19M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $1.48M derived: sum of 2 quarters · filed 2026-03-31 | $9.03M 20-F · filed 2026-03-31 | |
| 2025-09-30 | $289.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $7.84M 6-K · filed 2025-11-26 | ||
| 2025-06-30 | $7.55M 6-K · filed 2026-09-02 | |||
| 2024-12-31 | $448.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $8.79M 20-F · filed 2026-03-31 | ||
| 2024-09-30 | $8.34M 6-K · filed 2025-11-26 | |||
| 2023-12-31 | $6.18M 20-F · filed 2026-03-31 | |||
| 2022-12-31 | $70.00K 20-F · filed 2025-04-02 | |||
| 2021-12-31 | $17.37M 20-F · filed 2024-04-04 | |||
| 2021-06-30 | $17.37M 6-K · filed 2022-08-04 | |||
| 2020-12-31 | $768.00K 20-F · filed 2023-03-29 | |||
| 2020-06-30 | $61.00K 6-K · filed 2021-08-05 | |||
| 2019-12-31 | $143.00K 20-F · filed 2022-05-02 | |||
| 2019-06-30 | $95.00K 6-K · filed 2020-08-06 | |||
| 2018-12-31 | $80.18M 20-F · filed 2021-03-18 | |||
| 2018-06-30 | $80.04M 6-K · filed 2019-08-05 | |||
| 2017-12-31 | $15.55M 20-F · filed 2020-03-12 | |||
| 2017-06-30 | $247.00K 6-K · filed 2018-08-02 | |||
| 2016-12-31 | $4.73M 20-F · filed 2019-03-13 | |||
| 2015-12-31 | $0.00 20-F · filed 2018-03-13 |